Studies on the mechanism of nuclear-cytoplasmic transport -From the studies of the influenza virus assembly

核质转运机制研究——从流感病毒组装研究开始

基本信息

  • 批准号:
    05680589
  • 负责人:
  • 金额:
    $ 1.34万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)
  • 财政年份:
    1993
  • 资助国家:
    日本
  • 起止时间:
    1993 至 1994
  • 项目状态:
    已结题

项目摘要

We have realized that the studies of the influenza virus growth provide several interesting problems concerning nuclear-cytoplasmic transport. In the early stage of virus assembly, the virus genomic RNA produced in the nucleus immediately with virus core proteins, and the ribonucleoprotein complex (vRNP) thus formed is transported through the nuclear pore into the cytosol, and then into budding virus particles on the plasma membrane. In the first part of this study, nuclear-cytoplasmic transport of vRNPs was studied by analysing the distribution of vRNAs employing an in situ hybridization technique. The analyzes were performed using wild-type virus as well as a ts mutant virus, ts-51, which harbors a mutation in the segment 7, and has a defect in the late phase of virus growth. Nucleotide sequence analysis revealed a single amino acid change in the M1 protein. In the ts-51 virus-infected cells at a nonpermissive temperature, more than 95% of the vRNAs and the M1 protein remained in the nucleus, even at 6 hrpi and thereafter, when about 50% of them moved to the cytoplasm for the wild-type virus.These observations indicated that the M1 protein participated in the nuclear-cytoplasmic transport of the vRNAs. One hypothesis was that the M1 was associated with vRNPs in the nucleus forming possible M1-vRNP complexes, which were then transported into the cytosol. In the second part of this study, the virus assembly process in plasma membrane was investigated on the significance of the conserved sequence of the NA protein (its cytoplasmic domain and a successive sequence of the transmembrane domain) by the reverse genetic technique. It was indicated that both successive regions playd important roles in the formation of the infective virus particles.
我们已经认识到,流感病毒生长的研究提供了几个有趣的问题,有关核质运输。在病毒装配的早期阶段,在细胞核中产生的病毒基因组RNA立即与病毒核心蛋白结合,由此形成的核糖核蛋白复合物(vRNP)通过核孔转运到细胞质中,然后进入质膜上的出芽病毒颗粒。在本研究的第一部分,核质运输的vRNP进行了研究,采用原位杂交技术分析的vRNA的分布。使用野生型病毒以及ts突变病毒ts-51进行分析,ts-51在片段7中具有突变,并且在病毒生长的后期具有缺陷。核苷酸序列分析显示M1蛋白中的单个氨基酸变化。在非允许温度下,在ts-51病毒感染的细胞中,超过95%的vRNA和M1蛋白仍然留在细胞核中,即使在6 hrpi和之后,当野生型病毒的约50%的vRNA移动到细胞质时,这些观察表明M1蛋白参与了vRNA的核质转运。一种假设是M1与细胞核中的vRNP结合,形成可能的M1-vRNP复合物,然后转运到胞质溶胶中。在本研究的第二部分中,通过反向遗传技术研究了NA蛋白的保守序列(其胞质结构域和跨膜结构域的连续序列)在质膜中的组装过程中的意义。这表明两个连续区域在感染性病毒颗粒的形成中起重要作用。

项目成果

期刊论文数量(26)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
T.Takizawa 他5名: "Induction of programmed cell death(apoptosis)by influenza infection in tissue culture cells" J.General Virology. 74. 2347-2355 (1993)
T. Takizawa 和其他 5 人:“组织培养细胞中流感感染诱导程序性细胞死亡(细胞凋亡)”J. General Virology 74. 2347-2355 (1993)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
T.Takizawa: "Induction of Programmed Cell Death(Apoptosis)by Influenza Virus Infection in Tissue Culture Cells" J.General Virology. 74. 2347-2355 (1993)
T.Takizawa:“组织培养细胞中流感病毒感染诱导程序性细胞死亡(细胞凋亡)”J.General Virology。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
T.Takizawa: "Induction of the Apoptotic Fas Antigen-encoding Gene by Influenza Virus Infection" J.Virology. (in press). (1994)
T.Takizawa:“流感病毒感染诱导凋亡 Fas 抗原编码基因”J.Virology。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
H.Ohmori 他4名: "dinP,a new gene in Escherichia coli,whose product shows similarities to UmuC and its homolegues" Mutation Research Letters. (in press). (1995)
H. Ohmori 和其他 4 人:“dinP,大肠杆菌中的一种新基因,其产物与 UmuC 及其同源物相似”《突变研究快报》(1995 年出版)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
K.Enami, Y.Qiao, R.Fukuda, and M.Enami: "An influenza virus temperature-sensitive mutant defective in the nuclear-cytoplasmic transport of the negative-sense viral RNAs." Virology. 194. 822-827 (1993)
K.Enami、Y.Qiao、R.Fukuda 和 M.Enami:“一种流感病毒温度敏感突变体,其负义病毒 RNA 的核胞质运输存在缺陷。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

FIKUDA Ryuji其他文献

FIKUDA Ryuji的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

相似海外基金

Application of New Tools for Probing the Roles of Sphingolipids and Cholesterol in Influenza Virus Infection
应用新工具探索鞘脂和胆固醇在流感病毒感染中的作用
  • 批准号:
    10678459
  • 财政年份:
    2023
  • 资助金额:
    $ 1.34万
  • 项目类别:
Genetic and biophysical mechanisms that control influenza virus cellular multiplicity of infection
控制流感病毒细胞感染多重性的遗传和生物物理机制
  • 批准号:
    10659426
  • 财政年份:
    2023
  • 资助金额:
    $ 1.34万
  • 项目类别:
Unravelling highly pathogenic influenza virus emergence
揭开高致病性流感病毒出现的谜团
  • 批准号:
    10718091
  • 财政年份:
    2023
  • 资助金额:
    $ 1.34万
  • 项目类别:
Transcription, replication, trafficking and assembly of the influenza virus RNA genome
流感病毒RNA基因组的转录、复制、运输和组装
  • 批准号:
    MR/X008312/1
  • 财政年份:
    2023
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Research Grant
Assessment of PilVax nasal vaccine for preventing influenza virus infection
PilVax 鼻疫苗预防流感病毒感染的评估
  • 批准号:
    22KF0065
  • 财政年份:
    2023
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
DEVELOPMENT OF SMALL-MOLECULE DUAL ADJUVANT SYSTEM FOR INFLUENZA VIRUS VACCINE
流感病毒疫苗小分子双佐剂体系的研制
  • 批准号:
    10935796
  • 财政年份:
    2023
  • 资助金额:
    $ 1.34万
  • 项目类别:
Functional elucidation of influenza virus sialidase by intracellular enzymatic activity imaging probe.
通过细胞内酶活性成像探针阐明流感病毒唾液酸酶的功能。
  • 批准号:
    23K16306
  • 财政年份:
    2023
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
MULTIVALENT QS-18 PROTEIN NANOPARTICLES FOR A BROADLY PROTECTIVE INFLUENZA VIRUS VACCINE
用于广泛保护性流感病毒疫苗的多价 QS-18 蛋白纳米颗粒
  • 批准号:
    10933284
  • 财政年份:
    2023
  • 资助金额:
    $ 1.34万
  • 项目类别:
Cell-free synthesis of influenza virus-like particles (VLPs) as prototyping platform for vaccine development and variant characterization
流感病毒样颗粒 (VLP) 的无细胞合成作为疫苗开发和变体表征的原型平台
  • 批准号:
    10648472
  • 财政年份:
    2023
  • 资助金额:
    $ 1.34万
  • 项目类别:
Task V32: MANUFACTURE OF INFLUENZA VIRUS HUMAN CHALLENGE MATERIAL FOR PHASE 1 AND 2
任务 V32:1 期和 2 期流感病毒人类挑战材料的制造
  • 批准号:
    10938084
  • 财政年份:
    2023
  • 资助金额:
    $ 1.34万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了